全文获取类型
收费全文 | 537篇 |
免费 | 26篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 29篇 |
妇产科学 | 5篇 |
基础医学 | 40篇 |
口腔科学 | 1篇 |
临床医学 | 48篇 |
内科学 | 198篇 |
皮肤病学 | 47篇 |
神经病学 | 17篇 |
特种医学 | 14篇 |
外科学 | 24篇 |
综合类 | 20篇 |
预防医学 | 7篇 |
眼科学 | 6篇 |
药学 | 42篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 13篇 |
2020年 | 8篇 |
2019年 | 16篇 |
2018年 | 9篇 |
2017年 | 6篇 |
2016年 | 11篇 |
2015年 | 27篇 |
2014年 | 27篇 |
2013年 | 18篇 |
2012年 | 54篇 |
2011年 | 58篇 |
2010年 | 35篇 |
2009年 | 26篇 |
2008年 | 35篇 |
2007年 | 34篇 |
2006年 | 31篇 |
2005年 | 31篇 |
2004年 | 23篇 |
2003年 | 36篇 |
2002年 | 27篇 |
2001年 | 4篇 |
2000年 | 1篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 2篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1960年 | 2篇 |
1959年 | 1篇 |
1958年 | 1篇 |
1957年 | 1篇 |
1956年 | 2篇 |
1955年 | 1篇 |
1954年 | 1篇 |
1950年 | 2篇 |
1949年 | 1篇 |
排序方式: 共有564条查询结果,搜索用时 15 毫秒
1.
A two-and-a-half-year-old male child presented with recurrent attacks of intractable vomiting, psychomotor retardation since
14 months of age. He had also lower cranial nerve palsy and corticospinal involvement. Magnetic resonance imaging had shown
multiple well circumscribed areas of hypointusity in T, weighted image which were brightly hyperintense in heavily T2-weighted image. The lesions were seen in basal ganglia, thalamii and brainstenvand spared mamillary bodies. Magnetic resonance
spectroscopy demonstrated lactate peak in the affected areas confirming the diagnosis of Leigh’s disease. The child responded
well to large dose of vitamin ‘B’, therapy. 相似文献
2.
Prevalence and Predictors of Left Ventricular Diastolic Dysfunction in a Hispanic Patient Population
Carlos E. Rodríguez Castro Alexander Lyapin Mithun Pattathan José Negrin Debabrata Mukherjee 《The International journal of angiology》2013,22(4):229-234
Minimal data exist on attributes of diastolic dysfunction in the Hispanic population. The purpose of this study was to evaluate the prevalence and predictors of diastolic dysfunction in a Hispanic patient population. We performed a retrospective review of 166 consecutive echocardiograms in a southwestern Texas Hospital that caters to a large Hispanic patient population. We identified all echocardiograms that met criteria for diastolic dysfunction and assessed baseline demographics and comorbidities in the cohort of Hispanic patients. A multivariate analysis was performed to identify the independent predictors of diastolic dysfunction. A total of 129 out of 166 patients (77.8%) were of Hispanic origin. Out of the 129 patients, 87 (67.4%) had some degree of diastolic dysfunction in this population suggesting a high prevalence in the study cohort. In the diastolic dysfunction group, the mean age was 64.5 ± 13.9, 37% were male and 63% female, 78% had diabetes, 85% had hypertension, and 49% had some degree of renal insufficiency (stages 3–5). A logistic multivariate analysis showed that diabetes was an independent predictor of diastolic dysfunction with odds ratio of 2.69 (95% confidence interval [CI], 1.06–6.28; p = 0.038). Similarly age (per year increase) and chronic kidney disease were independent predictors of diastolic dysfunction. We demonstrated that older age, presence of diabetes, and renal dysfunction are independent predictors of diastolic dysfunction in the Hispanic patient population. Strategies geared toward reducing diabetes and preventing renal dysfunction are likely to decrease prevalence of diastolic dysfunction and heart failure in this community. 相似文献
3.
4.
Mukherjee D 《Cardiology Clinics》2005,23(2):185-191
Revascularization with CABG or angioplasty in diabetic patients is associated with a less favor-able outcome. The value of early intervention will be assessed in the ongoing BARI 2D trial. It remains to be determined whether the widespread use of GP IIb/IIIa drugs and prolonged dual antiplatelet therapy in diabetic patients who receive stents, and possibly drug-eluting stents, will alter results significantly so that outcomes become comparable or even better than CABG (Fig. 3). It seems prudent to consider CABG with LIMA grafting in diabetic patients who have severe multi-vessel disease and to consider angioplasty in selected patients who have more discrete and less severe disease. 相似文献
5.
Aortic dissection--an update 总被引:7,自引:0,他引:7
Acute aortic dissection is a medical emergency with high morbidity and mortality requiring emergent diagnosis and therapy. Rapid advances in noninvasive imaging technology have facilitated the early diagnosis of this condition and should be considered in the differential diagnosis of any patient with chest, back, or abdominal pain. Emergent surgery is the treatment for patients with type A dissection while optimal medical therapy is appropriate in patients with uncomplicated type B dissection. Adequate beta-blockade is the cornerstone of medical therapy. Patients who survive acute aortic dissection need long-term medical therapy with beta-blockers and statins and appropriate serial imaging follow-up. Future advances in this field include biomarkers in the early diagnosis of acute aortic dissection and presymptomatic diagnosis with genetic screening. Overall patients with aortic dissection are at high risk for an adverse outcome and need to be managed aggressively in hospital and long term with frequent follow-up. 相似文献
6.
7.
Shelf-price agreements: the next frontier in competitive bidding for coronary intervention supplies.
Robert K Keast Kim A Eagle Julie Goldstein-Dunn Douglas Cox Catherine Gage Michalak Stanley Chetcuti P Michael Grossman Debabrata Mukherjee Linda R Larin Stephen Fetyko T Anthony Denton Mauro Moscucci 《The Journal of cardiovascular management》2005,16(3):27-30
In an attempt to further reduce operating costs, in 2004 our institution embarked on a novel approach in which we defined the price to be paid for interventional cardiology supplies and challenged vendors to meet that price. The results suggest that this strategy can further reduce supply costs while maintaining collaborative relationships with vendors. 相似文献
8.
9.
Chatterjee S Ghosh J Lichstein E Aikat S Mukherjee D 《The American journal of cardiology》2012,110(4):607-613
Dronedarone is a benzofuran derivative approved by the Food and Drug Administration to decrease the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) and associated cardiovascular risk factors who are in sinus rhythm or will undergo cardioversion. There has been recent evidence to suggest that dronedarone may not have a favorable safety profile. We decided to evaluate all available evidence on the cardiovascular safety of this drug. A systematic search was made of the PubMed, CENTRAL, and EMBASE databases for randomized controlled trials from 1966 through 2011 comparing dronedarone to comparators in AF/heart failure. Intervention was dronedarone for AF for some studies and heart failure for others. Comparators included standard medical therapy and/or placebo and amiodarone for 1 study. Outcomes assessed were all-cause mortality, cardiovascular mortality, ventricular arrhythmias, embolic events, acute coronary syndrome, heart failure exacerbations, and hospitalization rates in the intervention versus comparator group at the end of ≥ 3 months of follow up with abstraction of data by 1 author. Seven randomized controlled trials were included in our analysis. Dronedarone use was associated with a trend toward worse all-cause and cardiovascular mortalities and increased heart failure exacerbations. It also showed numerically higher event rates for all other outcome events except acute coronary syndrome. Our pooled analysis showed increased all-cause and cardiovascular mortalities and increased heart failure exacerbations with use of dronedarone across a wide spectrum of populations. In conclusion, we recommend exercising caution using dronedarone, especially in patients with cardiovascular risk factors. 相似文献
10.
Stroke remains a major cause of morbidity and mortality worldwide. Despite preventive measures, effective management strategies are needed to reduce the morbidity and mortality associated with this devastating condition. While the management of hemorrhagic stroke is mostly limited to supportive care, reperfusion strategies in ischemic stroke have been developed and continue to evolve. Conceptually, the pathophysiology of ischemic stroke is similar to that of acute myocardial infarction and the objective of management is similar (ie, to rapidly restore normal flow to reduce permanent damage). It is, therefore, not surprising that the management of acute ischemic stroke includes intravenous (IV) thrombolysis, the only Food and Drug Administration (FDA)-approved strategy at this point. In addition, there are a myriad of emerging endovascular interventional techniques. We review the current literature and discuss some of the technical aspects of endovascular therapy in the setting of acute ischemic stroke. 相似文献